A ARIAD PHARMACEUTICALS INC: directors' dealings · United States · SEC (Form 4) Explore the full insider trade history of ARIAD PHARMACEUTICALS INC, a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €92.8m. The latest transaction was reported on 9 February 2016 (Attribution). Among the most active insiders: BERGER HARVEY J M D. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 9 February 2016
All Executives33 Thresholds0 Prospectus0 Other0
Declarations 33 total
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-040253:0
◇ SVP, Corporate Affairs · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039302:0
▼ SVP, Corporate Affairs · Executives · 1 Feb 2016
1,466 shares Common Stock SEC:0001127602-16-039302:1
▼ SVP, Corporate Affairs · Executives · 1 Feb 2016
14,667 shares Common Stock SEC:0001127602-16-039302:2
◇ Executive VP, CFO · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039303:0
▼ Executive VP, CFO · Executives · 1 Feb 2016
14,667 shares Common Stock SEC:0001127602-16-039303:1
◇ SVP, Chief IP Counsel · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039305:0
▼ SVP, Chief IP Counsel · Executives · 1 Feb 2016
14,667 shares Common Stock SEC:0001127602-16-039305:1
◇ SVP, Clinical R&D, CMO · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039308:0
▼ SVP, Clinical R&D, CMO · Executives · 1 Feb 2016
16,133 shares Common Stock SEC:0001127602-16-039308:1
◇ Sr. VP, Reg. Affairs & Quality · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039311:0
▼ EVP, CCO · Executives · 1 Feb 2016
14,667 shares Common Stock SEC:0001127602-16-039321:1
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039325:0
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039329:0
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039334:0
◆ Director · Executives · 1 Feb 2016
23,902 shares Common Stock SEC:0001127602-16-039337:0
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039344:0
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039345:0
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039346:0
◆ Director · Executives · 1 Feb 2016
12,500 shares Common Stock SEC:0001127602-16-039358:0
▲ President and CEO · Executives · 1 Feb 2016
61,099 shares Common Stock SEC:0001127602-16-039363:0
Ideal exit: 28 Oct 2016 (T+270) ◇ President, R&D, CSO · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039317:0
▼ President, R&D, CSO · Executives · 1 Feb 2016
14,667 shares Common Stock SEC:0001127602-16-039317:1
◇ EVP, CCO · Executives · 1 Feb 2016
29,333 shares Common Stock SEC:0001127602-16-039321:0
▼ Sr. VP, Reg. Affairs & Quality · Executives · 1 Feb 2016
14,667 shares Common Stock SEC:0001127602-16-039311:1
25 of 33 declarations
Load more (8 remaining)